PDS Biotechnology
Stephan Toutain is an experienced executive in the biotechnology sector, currently serving as Chief Operating Officer at PDS Biotechnology and Anavex Life Sciences. Previously, Stephan held the position of Chief Commercial Officer at Interleukin Genetics and served as a Member of the Board of Directors for Targeted Cancer Therapeutics. Additionally, Stephan has worked as an Executive Consultant in the biotech field. Educational background includes studies at the University of North Carolina at Chapel Hill - Kenan-Flagler Business School and the Business Institute of Lyon.
This person is not in any teams
This person is not in any offices
PDS Biotechnology
PDS Biotechnology Corporation is a biopharmaceutical company. It develops immunotherapies for cancer and other infectious diseases. It develops products to prevent and treat cervical, ovarian, melanoma, leukemia, pancreatic, oral, multiple myeloma, anal, vulvar, and penile cancers. The company offers PDS0101, a treatment for HPV-related cancers;PDS0102, a pandemic influenza vaccine; and PDS0103, a line of immunotherapy products for non-viral cancers.PDS Biotechnology Corporation was founded in 2005 and is headquartered in North Brunswick, New Jersey.